Intracerebroventricular (ICV) administration of an adeno-associated virus serotype 9 (AAV9) carrying CLN5 was able to prevent or halt brain atrophy and cognitive decline in both pre- and post-symptomatic CLN5−/− sheep, and delay but not prevent loss of vision (20). The gene discussed is CLN5; the disease is Brain atrophy.